(Q46620513)

23 December 2017

title

Mixed-lineage eosinophil/basophil crisis in MDS: a rare form of progression (English)

1 reference

23 December 2017

author name string

F Wimazal

1

1 reference

23 December 2017

C Baumgartner

2

1 reference

23 December 2017

K Sonneck

3

1 reference

23 December 2017

C Zauner

4

1 reference

23 December 2017

P Geissler

5

1 reference

23 December 2017

S Schur

6

1 reference

23 December 2017

P Samorapoompichit

7

1 reference

23 December 2017

L Müllauer

8

1 reference

23 December 2017

M Födinger

9

1 reference

23 December 2017

H Agis

10

1 reference

23 December 2017

W R Sperr

11

1 reference

23 December 2017

P Valent

12

1 reference

23 December 2017

publication date

24 April 2008

1 reference

23 December 2017

European Journal of Clinical Investigation

published in

1 reference

23 December 2017

volume

38

1 reference

23 December 2017

issue

6

1 reference

23 December 2017

page(s)

447-455

1 reference

23 December 2017

A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing Committee for the Collaborative CML Prognostic Factors Project Group.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01950.X

Characteristics of accelerated disease in chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01950.X

Transformation of chronic myelogenous leukemia: clinical, morphologic, and cytogenetic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01950.X

Acute Basophilic Leukemia: A Clinical, Morphologic, and Cytogenetic Study of Eight Cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01950.X

Myelomastocytic leukemia: myeloid neoplasm characterized by partial differentiation of mast cell-lineage cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01950.X

Myelomastocytic leukemia: evidence for the origin of mast cells from the leukemic clone and eradication by allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01950.X

Mast cell-lineage versus basophil lineage involvement in myeloproliferative and myelodysplastic syndromes: diagnostic role of cell-immunophenotyping.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01950.X

Myelomastocytic overlap syndromes: biology, criteria, and relationship to mastocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01950.X

Mast cell leukemia: report of a case and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01950.X

Mastocytosis: pathology, genetics, and current options for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01950.X

Proposals for the classification of the myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01950.X

The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposals by the French-American-British Cooperative Leukaemia Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01950.X

Mutation analysis of C-KIT in patients with myelodysplastic syndromes without mastocytosis and cases of systemic mastocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01950.X

A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01950.X

Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01950.X

Enumeration and immunohistochemical characterisation of bone marrow basophils in myeloproliferative disorders using the basophil specific monoclonal antibody 2D7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01950.X

Detection of tryptase in cytoplasmic granules of basophils in patients with chronic myeloid leukemia and other myeloid neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01950.X

Evaluation of neoplastic human mast cells by tryptase-immunoelectron microscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01950.X

Interleukin 3 activates human blood basophils via high-affinity binding sites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01950.X

Kit and c-kit mutations in mastocytosis: a short overview with special reference to novel molecular and diagnostic concepts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01950.X

Variable expression of activation-linked surface antigens on human mast cells in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01950.X

Diagnosis of mastocytosis: general histopathological aspects, morphological criteria, and immunohistochemical findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01950.X

Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01950.X

Diagnostic value of histology and immunohistochemistry in myelodysplastic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01950.X

The FIP1L1-PDGFRalpha fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01950.X

FIP1L1-PDGFRA in eosinophilic disorders: prevalence in routine clinical practice, long-term experience with imatinib therapy, and a critical review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01950.X

Acute basophilic leukemia: case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01950.X

Activity of imatinib in systemic mastocytosis with chronic basophilic leukemia and a PRKG2-PDGFRB fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01950.X

Prevalence and clinical characteristics of myelodysplastic syndrome with bone marrow eosinophilia or basophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01950.X

Quantitative, phenotypic, and functional evaluation of basophils in myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01950.X

10.1111/J.1365-2362.2008.01950.X

21 January 2018

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017